Production (Stage)
Eledon Pharmaceuticals, Inc.
ELDN
$2.87
-$0.13-4.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 72.51% | -48.23% | 877.01% | 31.71% | -119.37% |
| Total Depreciation and Amortization | -- | -6.38% | -15.96% | 3.19% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -153.42% | 25.51% | -11,919.65% | -41.40% | 959.02% |
| Change in Net Operating Assets | -761.51% | -121.46% | 309.42% | 980.22% | 142.40% |
| Cash from Operations | -83.73% | -107.94% | 3.93% | 5.44% | 11.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.22% | -570.25% | 48.85% | 34.35% | -- |
| Cash from Investing | -60.22% | -570.25% | 48.85% | 34.35% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11,400.00% | -- | -- | 45.59% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11,400.00% | -- | -- | 45.59% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,255.61% | 1,360.11% | 48.26% | 468.08% | 110.51% |